Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

760
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
760
Aging01:26

Aging

663
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
663
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.7K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.7K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

3.4K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.4K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.2K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncostatin M suppresses EGF-mediated protein tyrosine phosphorylation in breast cancer cells.

Cytokine·2000
Same author

Effects of cyclopentyladenosine on isoproterenol response in adult and senescent cardiac tissue from Fischer 344 rats.

The Journal of pharmacology and experimental therapeutics·2000
Same author

Cloning and characterization of human oncostatin M promoter.

Nucleic acids research·1999
Same author

Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.

The Journal of pharmacology and experimental therapeutics·1999
Same author

Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.

The Journal of pharmacology and experimental therapeutics·1999
Same author

Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study.

Journal of protein chemistry·1998
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Related Experiment Video

Updated: Jan 27, 2026

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
07:04

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

5.8K

Aging and pharmacology

R E Vestal1

  • 1Department of Veterans Affairs Medical Center, and Mountain States Medical Research Institute, Boise, Idaho 83702, USA.

Cancer
|October 8, 1997
PubMed
Summary
This summary is machine-generated.

Geriatric clinical pharmacology focuses on aging and drug effects in older adults, particularly those with cancer. Further research is needed to improve medication use and care for elderly cancer patients.

More Related Videos

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
11:57

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans

Published on: November 26, 2017

9.2K
Pharmacological and Functional Genetic Assays to Manipulate Regeneration of the Planarian Dugesia japonica
09:58

Pharmacological and Functional Genetic Assays to Manipulate Regeneration of the Planarian Dugesia japonica

Published on: August 31, 2011

37.6K

Related Experiment Videos

Last Updated: Jan 27, 2026

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
07:04

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

5.8K
Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
11:57

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans

Published on: November 26, 2017

9.2K
Pharmacological and Functional Genetic Assays to Manipulate Regeneration of the Planarian Dugesia japonica
09:58

Pharmacological and Functional Genetic Assays to Manipulate Regeneration of the Planarian Dugesia japonica

Published on: August 31, 2011

37.6K

Area of Science:

  • Geriatric clinical pharmacology
  • Clinical pharmacology
  • Oncology

Background:

  • Geriatric clinical pharmacology is a subdiscipline of clinical pharmacology.
  • Older adults with cancer present unique challenges in drug management.
  • Current knowledge on drug use in this population is limited.

Purpose of the Study:

  • To review the current state of knowledge on geriatric clinical pharmacology in cancer care.
  • To identify gaps in research regarding medication use in older cancer patients.
  • To highlight the need for collaboration between geriatric pharmacologists and oncologists.

Main Methods:

  • Literature review of drug utilization in older cancer patients.
  • Examination of pharmacokinetics and pharmacodynamics in this demographic.
  • Analysis of adverse drug events, interactions, and polypharmacy.

Main Results:

  • Information on drug utilization, pharmacokinetics, pharmacodynamics, adverse events, and polypharmacy in older cancer patients is reviewed.
  • Data on cancer chemotherapy in aging populations is notably sparse.
  • Significant research potential exists in this field.

Conclusions:

  • There is a substantial need for clinical research in geriatric oncology pharmacology.
  • Partnerships between geriatric clinical pharmacologists and medical oncologists are crucial.
  • Improved understanding can enhance treatment and care for older patients with cancer.